All articles by Vidya Sagar Maddela
Vidya Sagar Maddela
MediBeacon gets FDA nod for TGFR System to assess kidney function
The Transdermal GFR System (TGFR) enables point-of-care assessment of kidney function in patients with normal or impaired renal function across the adult population without input of age, weight, sex, gender, race, or ethnicity
NAMSA acquires WuXi AppTecs’s US medical device testing business
NAMSA will acquire WuXi AppTec’s medical device testing facilities in Minnesota and Georgia, with all other Contract Research, Development, and Manufacturing Organisation (CRDMO) operations remaining unaffected
Leica Biosystems Supercharges Digital Pathology with Game-Changing Aperio GT 450 Enhancements
The company offers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting
Oxford Brain Diagnostics secures FDA 510(k) approval for CDM Insights
Designed using Oxford Brain Diagnostics’ Cortical Disarray Measurement (CDM) technology, CDM Insights is a cloud-native software solution that provides a deeper understanding of the brain’s microstructure from MRI scans
Medtronic’s LINQ family of ICMs can accurately predict AF
Based on results from the DEFINE AFib study, Medtronic’s ICMs with AI algorithms could detect Afib episodes and differentiate high-risk patients before an AF-related healthcare utilisation 80% of the time
Kardia 12L ECG System Receives CMS Reimbursement Approval
AliveCor, Inc., the leading provider of FDA-cleared personal electrocardiogram (ECG) technology, is transforming cardiology with its medical-grade AI solutions
UCSF, GE HealthCare enter joint research collaboration
The new joint research collaboration, which builds on a decades-long relationship, integrates UCSF’s research and clinical expertise with GE HealthCare’s deep knowledge in the research and product development
Beckman Coulter rolls out RUO tests for neurodegenerative diseases
The new RUO assays, intended for use on the DxI 9000 Immunoassay Analyser, evaluate p-Tau217, GFAP, NfL, and APOE ε4 biomarkers, which play a key role in neurodegenerative disease research
Eurofins Viracor Launches New Quantitative PCR Assay for Chagas Disease Diagnosis
Eurofins is Testing for Life. With ca. 62,000 staff across a network of more than 900 laboratories in over 1,000 companies in 62 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Argon Medical to acquire SeQure and DraKon microcatheters
The SeQure and DraKon microcatheters are commonly used by physicians in interventional procedures to introduce therapeutic agents or devices into the small vessels delivering blood to a tumour or abnormality